Literature DB >> 21472140

Neoplastic transformation induced by the gep oncogenes involves the scaffold protein JNK-interacting leucine zipper protein.

Kimia Kashef1, Rangasudhagar Radhakrishnan, Clement M Lee, E Premkumar Reddy, Danny N Dhanasekaran.   

Abstract

The activated mutants of the α-subunits of G proteins G(12) and G(13) have been designated as the gep oncogenes owing to their ability to stimulate diverse oncogenic signaling pathways that lead to neoplastic transformation of fibroblast cell lines and tumorigenesis in nude mice models. Studies from our laboratory as well as others have shown that the growth-promoting activities of Gα(12) and Gα(13) involve potent activation of c-Jun N-terminal kinases (JNKs). Our previous studies have indicated that the JNK-interacting leucine zipper protein (JLP), a scaffold protein involved in the structural and functional organization of the JNK/p38 mitogen-activated protein kinase module, tethers Gα(12) and Gα(13) to the JNK signaling module. In the present study, in addition to demonstrating the physical association between JLP and Gα(12), we show that this interaction is enhanced by the receptor- or mutation-mediated activation of Gα(12). We also establish that JLP interacts with Gα(12) through the C-terminal domain that has been previously identified to be involved in binding to Gα(13). Furthermore, using this C-terminal domain as a competitively inhibitor of JLP that can disrupt Gα(12)-JLP interaction, we demonstrate that JLP is required for the stimulation of JNK by Gα(12). Our results also indicate that such JLP interaction is required for Gα(12) as well as Gα(13)-mediated neoplastic transformation of JLP. These studies demonstrate for the first time a functional role for JLP in the gep oncogene-regulated neoplastic signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21472140      PMCID: PMC3071084          DOI: 10.1593/neo.101622

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  34 in total

1.  Differential input by Ste5 scaffold and Msg5 phosphatase route a MAPK cascade to multiple outcomes.

Authors:  Jessica Andersson; David M Simpson; Maosong Qi; Yunmei Wang; Elaine A Elion
Journal:  EMBO J       Date:  2004-06-10       Impact factor: 11.598

2.  Galpha12 and Galpha13 regulate extracellular signal-regulated kinase and c-Jun kinase pathways by different mechanisms in COS-7 cells.

Authors:  T A Voyno-Yasenetskaya; M P Faure; N G Ahn; H R Bourne
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

3.  c-Jun amino-terminal kinase is regulated by Galpha12/Galpha13 and obligate for differentiation of P19 embryonal carcinoma cells by retinoic acid.

Authors:  E H Jho; R J Davis; C C Malbon
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

4.  Biological assays for cellular transformation.

Authors:  A D Cox; C J Der
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

5.  A mutant alpha subunit of G12 potentiates the eicosanoid pathway and is highly oncogenic in NIH 3T3 cells.

Authors:  N Xu; L Bradley; I Ambdukar; J S Gutkind
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

6.  JNK-interacting leucine zipper protein is a novel scaffolding protein in the Galpha13 signaling pathway.

Authors:  Kimia Kashef; Clement M Lee; Ji Hee Ha; E Premkumar Reddy; Danny N Dhanasekaran
Journal:  Biochemistry       Date:  2005-11-01       Impact factor: 3.162

7.  Transactivation of platelet-derived growth factor receptor alpha by the GTPase-deficient activated mutant of Galpha12.

Authors:  Rashmi N Kumar; Ji Hee Ha; Rangasudhagar Radhakrishnan; Danny N Dhanasekaran
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

8.  Galpha13 stimulates cell migration through cortactin-interacting protein Hax-1.

Authors:  V Radhika; Djamila Onesime; Ji Hee Ha; N Dhanasekaran
Journal:  J Biol Chem       Date:  2004-08-31       Impact factor: 5.157

Review 9.  Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.

Authors:  N Panupinthu; H Y Lee; G B Mills
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

Review 10.  The Ste5p scaffold.

Authors:  E A Elion
Journal:  J Cell Sci       Date:  2001-11       Impact factor: 5.285

View more
  11 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

3.  SPAG9 is overexpressed in osteosarcoma, and regulates cell proliferation and invasion through regulation of JunD.

Authors:  Chi Xiao; Lin Fu; Chongnan Yan; Fenyong Shou; Qi Liu; Lei Li; Shaoqian Cui; Jingzhu Duan; Guoxin Jin; Jianhua Chen; Yuanming Bian; Xu Wang; Huan Wang
Journal:  Oncol Lett       Date:  2016-07-29       Impact factor: 2.967

4.  SPAG9 is overexpressed in human prostate cancer and promotes cancer cell proliferation.

Authors:  Hui Li; Yang Peng; Huiyan Niu; Baogang Wu; Yi Zhang; Yue Zhang; Xue Bai; Ping He
Journal:  Tumour Biol       Date:  2014-04-17

5.  The gep proto-oncogene Gα13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells.

Authors:  Jacob A Gardner; Ji Hee Ha; Muralidharan Jayaraman; Danny N Dhanasekaran
Journal:  Pancreas       Date:  2013-07       Impact factor: 3.327

6.  SPAG9 is overexpressed in human astrocytoma and promotes cell proliferation and invasion.

Authors:  Fuxin Yi; Weimin Ni; Wenda Liu; Xiaodong Pan; Xiubin Han; Lei Yang; Xiangquan Kong; Rui Ma; Rui Chang
Journal:  Tumour Biol       Date:  2013-05-22

7.  Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

8.  G12 signaling through c-Jun NH2-terminal kinase promotes breast cancer cell invasion.

Authors:  Juhi Juneja; Ian Cushman; Patrick J Casey
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

9.  MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.

Authors:  Suhail Ahmed Kabeer Rasheed; Cui Rong Teo; Emmanuel Jean Beillard; P Mathijs Voorhoeve; Wei Zhou; Sujoy Ghosh; Patrick J Casey
Journal:  Mol Cancer       Date:  2015-03-26       Impact factor: 27.401

10.  Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer.

Authors:  Ji Hee Ha; Mingda Yan; Rohini Gomathinayagam; Muralidharan Jayaraman; Sanam Husain; Jinsong Liu; Priyabrata Mukherjee; E Premkumar Reddy; Yong Sang Song; Danny N Dhanasekaran
Journal:  Oncotarget       Date:  2016-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.